Anaesthesia — Cost, Top Hospitals & Success Rates | MyMedicPlus

Anaesthesia is the medically induced state that enables patients to undergo surgical or diagnostic procedures without pain, distress, or awareness. The term derives from the Greek meaning 'without sensation.' Modern anaesthesia encompasses a spectrum of techniques — from topical or local anaesthesia for minor procedures, through regional anaesthesia (nerve blocks, spinal, epidural) for limb and body-cavity procedures, to general anaesthesia (GA) for major surgery — each selected based on the procedure type, patient condition, and patient preference after informed consent.

The history of anaesthesia begins with the first public demonstration of ether anaesthesia by William Morton at Massachusetts General Hospital in 1846. Today's anaesthetic practice has evolved into a complex perioperative specialty — anaesthesiologists manage not only intraoperative unconsciousness and analgesia but also peri-operative airway management, haemodynamic stability, fluid therapy, transfusion, temperature regulation, and post-operative pain control as part of an Enhanced Recovery After Surgery (ERAS) framework.

General anaesthesia produces a reversible state of unconsciousness, analgesia (pain-free state), and muscle relaxation through the administration of intravenous agents (propofol, thiopentone, ketamine, etomidate) for induction and maintenance with volatile inhalational agents (sevoflurane, desflurane, isoflurane) or total intravenous anaesthesia (TIVA using propofol and remifentanil infusions). Opioid analgesia (fentanyl, morphine, remifentanil) and muscle relaxants (rocuronium, suxamethonium — reversed with sugammadex or neostigmine) complete the triad of general anaesthesia: hypnosis, analgesia, and relaxation.

Regional anaesthesia uses local anaesthetic drugs (lidocaine, bupivacaine, ropivacaine, levobupivacaine) to block nerve impulse transmission in specific anatomical regions, producing surgical anaesthesia and analgesia without loss of consciousness. It is preferred for many peripheral and lower body surgeries as it avoids systemic effects of general anaesthesia and provides superior postoperative pain control with reduced opioid requirements.

General anaesthesia (GA): Indicated for major surgical procedures on the head, neck, thorax, abdomen, or pelvis; procedures requiring airway protection (patients at risk of aspiration, procedures in the lateral or prone position); paediatric surgery where cooperation cannot be assured; and major orthopaedic procedures. Airway management during GA uses a face mask (simple, short procedures), supraglottic airway device (laryngeal mask airway — LMA, i-gel — for spontaneous breathing during intermediate procedures), or endotracheal intubation (for procedures requiring positive pressure ventilation, risk of aspiration, prolonged procedures).

Spinal anaesthesia (intrathecal block): Injection of local anaesthetic (typically hyperbaric bupivacaine 0.5%) into the cerebrospinal fluid in the lumbar subarachnoid space, producing dense sensory and motor block of the lower body within 5–10 minutes. Provides excellent surgical anaesthesia for procedures below the umbilicus: lower limb surgery, inguinal hernia repair, cystoscopy, TURP (transurethral prostatectomy), caesarean section (the gold standard for obstetric anaesthesia). Duration is 2–4 hours for standard spinal doses.

Epidural anaesthesia: Local anaesthetic injected into the epidural space through an epidural catheter placed in the thoracic or lumbar region. More controllable and longer-acting than spinal — allows continuous infusion of local anaesthetic for thoracic surgery, major abdominal surgery, and labour analgesia. Epidural analgesia after major surgery (thoracotomy, laparotomy, vascular surgery) reduces post-operative pulmonary complications and opioid consumption in RCTs and systematic reviews.

Peripheral nerve blocks: Ultrasound-guided injection of local anaesthetic adjacent to specific peripheral nerves or nerve plexuses to provide targeted anaesthesia and analgesia. Key blocks include interscalene (shoulder surgery), infraclavicular/axillary (upper limb), femoral + sciatic (lower limb), adductor canal block (knee arthroplasty analgesia — opioid-sparing with preserved quadriceps function), transversus abdominis plane (TAP) block for abdominal wall analgesia, erector spinae plane (ESP) block, and paravertebral block for thoracic surgery.

Monitored anaesthesia care (MAC) / Sedation: Titrated intravenous sedation (midazolam, fentanyl, propofol) combined with local anaesthesia for minor procedures (colonoscopy, endoscopy, cataract surgery, skin procedures) — patient is sedated and amnesic but breathing spontaneously. Deep sedation blurs the boundary with GA.

Pre-operative anaesthetic assessment is mandatory before elective surgery to identify conditions that increase anaesthetic risk, optimise the patient's medical condition before surgery, plan the anaesthetic technique, and obtain informed consent for anaesthesia risks. It is conducted in a pre-assessment clinic 1–6 weeks before elective surgery, or immediately before emergency procedures.

ASA Physical Status Classification System (American Society of Anesthesiologists): Stratifies patients into six classes based on systemic disease severity. ASA I (healthy, no systemic disease), ASA II (mild systemic disease — well-controlled hypertension, type 2 diabetes, mild asthma, obesity BMI 30–40), ASA III (severe systemic disease — poorly controlled diabetes, COPD, morbid obesity BMI ≥40, active hepatitis, dialysis-dependent renal failure, history of MI >3 months), ASA IV (severe systemic disease, constant threat to life — recent MI <3 months, severe COPD on home oxygen, sepsis, decompensated heart failure), ASA V (moribund, not expected to survive without operation), ASA VI (brain-dead organ donor). Higher ASA class correlates with higher perioperative morbidity and mortality.

Key elements of pre-operative assessment: Medical history (comorbidities, exercise tolerance — assessed in METs: inability to climb one flight of stairs = <4 METs, indicating high perioperative cardiac risk), previous anaesthetic history (family history of malignant hyperthermia, suxamethonium apnoea/pseudocholinesterase deficiency, difficult airway), current medications and allergies, airway assessment (Mallampati grade I–IV; mouth opening; neck mobility; thyromental distance; history of snoring/OSA suggesting potentially difficult intubation), fasting status, and cardiovascular risk assessment.

Fasting guidelines (UK AAGBI/US ASA): Solid food — 6 hours fast; breast milk — 4 hours; formula/non-breast milk — 6 hours; clear fluids — 2 hours (up to 2 hours before anaesthesia, clear water or clear tea/coffee without milk is permitted). Pre-operative carbohydrate loading drinks (maltodextrin) up to 2 hours before surgery are part of ERAS protocols, reducing insulin resistance and post-operative nausea.

Induction of general anaesthesia: IV propofol (1.5–2.5 mg/kg) is the most widely used induction agent for elective surgery — rapid onset (30–40 seconds), pleasant induction, antiemetic properties. Thiopentone (sodium thiopental) is the preferred induction agent when rapid sequence induction (RSI) is required for patients at aspiration risk. Ketamine (1–2 mg/kg IV) is used when haemodynamic stability is critical (trauma, haemorrhagic shock); it stimulates the sympathetic nervous system, maintaining blood pressure and heart rate while producing dissociative anaesthesia. Etomidate is used for induction in cardiac-compromised patients (minimal cardiovascular depression).

Maintenance of general anaesthesia: Volatile inhalational agents (sevoflurane 2–3% inspired; desflurane 6–8%; isoflurane 1–1.7%) delivered via a circle breathing system with oxygen and medical air (or nitrous oxide for short procedures). Total intravenous anaesthesia (TIVA) using propofol target-controlled infusion (TCI — Schnider or Marsh pharmacokinetic model, targeting a plasma concentration of 3–6 mcg/mL) combined with remifentanil TCI (ultra-short-acting opioid) provides TIVA without inhalational agents — preferred for procedures where awareness monitoring (BIS — bispectral index) is important, PONV-prone patients, or procedures requiring rapid wake-up (e.g., intraoperative neurological testing in awake craniotomy).

Muscle relaxation: Non-depolarising neuromuscular blocking drugs (NMBDs) including rocuronium (0.6–1.2 mg/kg) and atracurium are used to facilitate intubation and provide intraoperative relaxation for abdominal or thoracic procedures. Suxamethonium (succinylcholine) provides rapid-onset dense block for RSI in aspiration-risk patients. Neuromuscular blockade reversal with neostigmine + glycopyrrolate, or sugammadex (specific reversal for aminosteroid relaxants — rocuronium, vecuronium) at the end of surgery before extubation.

Intraoperative monitoring (minimum standards): ECG, pulse oximetry (SpO2), non-invasive blood pressure (NIBP), capnography (end-tidal CO2 — ETCO2 confirms correct airway placement and monitors ventilation), peripheral temperature, and volatile agent concentration. For major surgery: invasive arterial blood pressure monitoring (arterial line), central venous pressure (CVP) line, urinary catheter and urine output monitoring, cardiac output monitoring (LiDCO, PICCO, oesophageal Doppler), and core temperature monitoring.

Modern anaesthesia is extraordinarily safe by historical standards. Anaesthesia-related mortality in high-income countries has fallen from approximately 1 per 1,500 procedures in the 1950s to 1 per 100,000–200,000 procedures today — a 100-fold improvement driven by monitoring technology, pharmacological advances, systematic safety protocols, and subspecialty training.

Regional anaesthesia compared to general anaesthesia: RCT evidence and meta-analyses demonstrate that regional anaesthesia reduces postoperative pulmonary complications (relative risk reduction 30–40%), reduces deep vein thrombosis (by reducing the prothrombotic response to surgery), reduces blood loss during surgery (particularly hip arthroplasty, where spinal anaesthesia reduces intraoperative blood loss by 30–40%), and provides superior postoperative analgesia with reduced opioid consumption — reducing PONV, sedation, and facilitating earlier mobilisation and discharge under ERAS protocols.

Neuraxial analgesia (epidural, spinal): The combination of thoracic epidural analgesia with systemic analgesics is the gold standard for major thoracic and abdominal surgery, reducing post-operative pulmonary complications by 50–60% compared to systemic opioids alone (meta-analysis of RCTs). Epidural analgesia allows earlier ambulation, reduces ileus duration, and enables early oral nutrition — key ERAS benefits.

Postoperative nausea and vomiting (PONV) prevention: PONV occurs in 20–30% of patients after general anaesthesia and is the leading cause of patient dissatisfaction with anaesthesia. TIVA with propofol reduces PONV by 30–40%; dexamethasone (4–8 mg IV at induction) and ondansetron (4 mg IV at end of surgery) each provide 20–25% absolute risk reduction — combination multimodal prophylaxis using 3 antiemetics reduces PONV below 10% even in high-risk patients (female sex, non-smoker, history of PONV or motion sickness, postoperative opioid use — Apfel score).

Common minor complications: Postoperative nausea and vomiting (PONV) in 20–30% of GA patients without prophylaxis — managed with ondansetron, dexamethasone, metoclopramide. Sore throat after endotracheal intubation in 25–50% — typically resolves within 24–48 hours. Dental damage from laryngoscopy — patients with pre-existing dental disease are at higher risk; documented dental examination before intubation is standard. Shivering after general or regional anaesthesia — treated with forced air warming and IV pethidine. Headache after spinal anaesthesia (post-dural puncture headache — PDPH): occurs in 1–4% after spinal anaesthesia using standard 25–27G spinal needles; postural (worse upright, better lying flat), frontal/occipital; responds to bed rest, fluids, caffeine; severe cases treated with epidural blood patch (EBP — 15–20 mL patient's own blood injected into epidural space to tamponade the dural leak — 90% effective).

Serious complications: Pulmonary aspiration of gastric contents: risk 1 per 5,000–10,000 in elective patients; higher in emergency surgery (full stomach), obstetric patients, and obese patients. Aspiration of acidic gastric contents causes Mendelson's syndrome — chemical pneumonitis with hypoxia and respiratory failure. RSI with cricoid pressure and fasting guidelines minimise this risk. Failed intubation: occurs in 1 per 500 routine cases and 1 per 250 obstetric patients. The DAS (Difficult Airway Society) 2015 failed intubation guidelines provide a clear algorithm — final fallback is emergency front-of-neck airway (surgical cricothyroidotomy). Malignant hyperthermia (MH): Rare (1 per 100,000 GA with triggering agents) but potentially fatal pharmacogenetic reaction to volatile anaesthetics or suxamethonium — causing life-threatening hyperthermia, muscle rigidity, and metabolic acidosis in genetically susceptible patients (RYR1 gene mutation). Treatment: immediate dantrolene IV (2.5 mg/kg, repeated up to 10 mg/kg), remove triggering agent, active cooling, ICU admission. Anaphylaxis to anaesthetic agents: 1 per 13,000 anaesthetics — neuromuscular blocking agents are the most common trigger (rocuronium — NMBA allergy is the most common cause of anaesthetic anaphylaxis). Managed with adrenaline (epinephrine) 0.5 mg IM, IV fluids, bronchodilators.

Post-anaesthesia recovery takes place in the Post-Anaesthesia Care Unit (PACU or recovery room) — a dedicated area with one-to-one nursing, full monitoring, and access to emergency anaesthetic and medical support. Standard PACU discharge criteria (modified Aldrete score ≥9) include: awake and responsive, SpO2 >95% on air, stable vital signs, adequate pain control, and absence of PONV.

After general anaesthesia, patients typically spend 30–90 minutes in the PACU before transfer to the surgical ward. The immediate recovery period involves wearing-off of residual volatile agents, re-establishing normal consciousness and cognitive function, and post-operative pain assessment. Cognitive effects ('grogginess', short-term memory impairment) may persist for 24–48 hours after general anaesthesia in otherwise healthy adults; patients should be counselled not to drive, operate machinery, sign legal documents, or make important decisions for 24–48 hours after GA.

Post-operative cognitive dysfunction (POCD) is a recognised phenomenon of prolonged cognitive impairment after major surgery and anaesthesia, particularly in elderly patients (age >65 is the strongest risk factor). POCD at 3 months occurs in 10–15% of patients over 60 after major surgery — though the relative contributions of anaesthesia versus surgery, pain, inflammation, and sleep disruption are debated. Avoidance of benzodiazepines and anticholinergic drugs, use of regional rather than general anaesthesia, and maintaining physiological homeostasis (normoxia, normocapnia, normotension, normothermia, normovolaemia) during surgery are key strategies to minimise POCD risk.

After spinal anaesthesia, motor block typically wears off within 2–4 hours; sensation returns by 3–5 hours. Patients should not ambulate until motor power has returned to allow safe weight-bearing — typically 3–4 hours after a standard spinal dose. Urinary retention is common after spinal anaesthesia (20–30%) — in/out catheterisation if no void within 6 hours.

Anaesthesia costs are billed separately from surgical fees in most healthcare systems. In the United States, anaesthesia fees are calculated based on base units (procedure complexity) plus time units (typically 1 unit per 15 minutes), multiplied by the conversion factor (dollar value per unit — approximately $75–$100 per unit). A 2-hour abdominal surgery may generate 20–30 anaesthesia units, costing $1,500–$3,000 for anaesthesia alone. Complex cardiac or neurosurgical procedures generate $4,000–$8,000 in anaesthesia fees. Total perioperative anaesthetic cost (including preoperative assessment, intraoperative care, PACU, and pain service fees) adds $3,000–$10,000 to the overall surgery bill for major procedures.

In the United Kingdom, anaesthesia is provided by a consultant anaesthetist within the NHS without separate billing to the patient. Private UK anaesthesia fees for major surgery range from £600–£2,500 as a component of the total private surgical episode.

In India, anaesthesia fees at private hospitals are bundled into the overall surgical package cost rather than billed separately in most cases. The overall surgical package at a private hospital in India includes anaesthesia, surgeon's fees, operating theatre, nursing, and hospitalisation. Patients travelling to India for surgery can expect anaesthesia to be included within published package costs. The anaesthesiology departments at leading Indian private hospitals include both nationally and internationally trained consultant anaesthetists with subspecialty expertise in cardiac, paediatric, neuroanaesthesia, and obstetric anaesthesia. Thailand, Turkey, and Singapore similarly include anaesthesia within surgical package costs at most international hospitals, making cost comparison straightforward.

Conscious sedation (monitored anaesthesia care — MAC): A lighter alternative to general anaesthesia for minor and intermediate procedures — endoscopy, colonoscopy, minor dermatological procedures, cataract surgery — where the patient remains breathing spontaneously and maintains airway reflexes but is sedated and amnesic using short-acting IV agents (propofol, midazolam, fentanyl). Avoids the risks of general anaesthesia but is not appropriate for procedures requiring airway protection, muscle relaxation, or complete patient immobility.

Hypnosis as a complement to sedation: Hypno-sedation (local anaesthesia + hypnotherapy) has been evaluated for breast cancer surgery and thyroid surgery in small RCTs, showing reduced sedative drug requirements and comparable patient satisfaction to general anaesthesia. Not widely available but offers an interesting option for patients particularly anxious about general anaesthesia.

Acupuncture for perioperative anxiety and PONV: Some patients use acupuncture (PC6 pericardium point stimulation — wristband or needling) as a complementary approach to reduce pre-operative anxiety and post-operative nausea; meta-analyses show modest benefit for PONV comparable to a single antiemetic medication. It does not replace pharmacological anaesthesia.

Local anaesthesia for minor surgery: For small skin lesions, dental procedures, peripheral nerve blocks for digit surgery, and minor procedures, infiltrated local anaesthetic alone is appropriate without any form of general or regional anaesthesia. Topical anaesthetic creams (EMLA — lidocaine/prilocaine eutectic mixture) are used for paediatric blood draws, cannula insertion, and minor dermatological procedures, avoiding the systemic risks of injectable anaesthetics for very minor procedures.